Pharmaceuticals

Global Regenerative Medicine For Cartilage Market Size, Forecasts, And Opportunities

December 23, 2021 by The Business Research Company

Learn about the global regenerative medicine for cartilage market through The Business Research Company, which provides information on regenerative medicine for cartilage market size, regenerative medicine for cartilage market drivers and restraints, regenerative medicine for cartilage market players, the COVID-19 impact on the regenerative medicine for cartilage market, and more.

Last chance at deals on TBRC’s market research reports! Get the best offer today.

The global regenerative medicine for cartilage market is expected to grow from $4.47 billion in 2020 to $4.83 billion in 2021 at a compound annual growth rate (CAGR) of 8.10%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $6.56 billion in 2025 at a CAGR of 7.94%.

The growing incidence of osteoarthritis across the globe is expected to drive innovation in regenerative medicine for cartilage manufacturing, thus driving the market during the forecast period.

Request A Sample For The Global Regenerative Medicine For Cartilage Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3961&type=smph

The regenerative medicine for cartilage market consists of sales of regenerative medicines for the cartilage by entities (organizations, sole traders, and partnerships) that have the capacity to grow muscles and organs in the lab and safely implant them when the body cannot regenerate itself, as observed for cartilage tissue after injury or wear. Only goods and services traded between entities or sold to end consumers are included.

Global regenerative medicine for cartilage market segments include:

By Treatment Modality: Cell-Based, Non-Cell-Based

By Treatment Type: Palliative, Intrinsic Repair Stimulus, Others

By Site: Knee Cartilage Repair, Ribs, Others

By Application: Hyaline Cartilage Repair and Regeneration, Elastic Cartilage Repair and Regeneration, Fibrous Cartilage Repair and Regeneration

By End-Use: Ambulatory Surgical Centres, Hospitals & Clinics, Surgical Centres, Others

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, Europe was the largest region in regenerative medicine for cartilage in 2020.

Tissue engineering and stem cell therapy are emerging trends in the regenerative medicine for cartilage market. The growth of tissue engineering technology has given hope for the regeneration of cartilage. Stem cell therapy is gaining attention with its advantages over traditional orthopaedic treatments. Stem cell therapy helps to reduce knee pain and improves knee cartilage regeneration and repair.

TBRC’s regenerative medicine for cartilage market report covers:

Major Market Players: B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Vericel Corporation, Stryker Corporation, Smith & Nephew plc, Arthrex Inc., CONMED Corporation, Collagen Solutions PLC, BioTissue Technologies, CellGenix, Osiris Therapeutics Inc., and DePuy Synthes.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)

The Regenerative Medicine For Cartilage Global Market Report 2021: COVID-19 Growth and Change to 2030 is one of a series of new reports from The Business Research Company that provides regenerative medicine for cartilage market overviews, analyses and forecasts market size, share, regenerative medicine for cartilage market players, regenerative medicine for cartilage market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s regenerative medicine for cartilage market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here Is A List Of Similar Reports From The Business Research Company:

Implantable Biomaterials Global Market Report 2021

Major Orthopedic Joint Replacement Implants Market

Orthopedic Braces And Support Devices And Equipment Global Market Report 2021

Interested To Know More About The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info

Check out our Blog: https://blog.tbrc.info/

Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model